X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (109) 109
index medicus (92) 92
humans (88) 88
united states (55) 55
united states food and drug administration (50) 50
female (48) 48
drug approval (45) 45
male (43) 43
aged (42) 42
middle aged (40) 40
adult (34) 34
antineoplastic agents - therapeutic use (29) 29
cancer (28) 28
treatment outcome (28) 28
aged, 80 and over (21) 21
disease-free survival (21) 21
clinical trials (19) 19
survival (19) 19
randomized controlled trials as topic (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
fda approval (14) 14
antineoplastic agents - adverse effects (13) 13
chemotherapy (13) 13
clinical trials as topic (13) 13
patients (13) 13
breast neoplasms - drug therapy (12) 12
breast neoplasms - pathology (11) 11
confidence intervals (11) 11
disease progression (11) 11
double-blind method (11) 11
protein kinase inhibitors - therapeutic use (10) 10
survival analysis (10) 10
adolescent (9) 9
animals (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
docetaxel (9) 9
immunotherapy (9) 9
neoplasm metastasis (9) 9
neoplasm staging (9) 9
therapy (9) 9
trial (9) 9
antineoplastic agents - pharmacology (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
clinical-trials (8) 8
fda (8) 8
lung neoplasms - drug therapy (8) 8
regulatory agencies (8) 8
regulatory issues (8) 8
clinical trials, phase iii as topic (7) 7
medical research (7) 7
metastasis (7) 7
pharmacology & pharmacy (7) 7
protein kinase inhibitors - adverse effects (7) 7
quality of life (7) 7
regulatory issues: fda (7) 7
antibodies, monoclonal - adverse effects (6) 6
carcinoma (6) 6
metastases (6) 6
multicenter studies as topic (6) 6
multiple myeloma - drug therapy (6) 6
neoplasms - drug therapy (6) 6
randomization (6) 6
time factors (6) 6
antineoplastic agents - pharmacokinetics (5) 5
approval (5) 5
breast cancer (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
carcinoma, squamous cell - drug therapy (5) 5
cell lung-cancer (5) 5
clinical trials as topic - methods (5) 5
clinical trials, phase ii as topic (5) 5
combination (5) 5
diarrhea (5) 5
drug administration schedule (5) 5
erlotinib (5) 5
fatigue (5) 5
infusions, intravenous (5) 5
leukemia (5) 5
lung neoplasms - pathology (5) 5
medical services (5) 5
melanoma (5) 5
melanoma - drug therapy (5) 5
melanoma - pathology (5) 5
multiple myeloma (5) 5
mutations (5) 5
nausea (5) 5
paclitaxel (5) 5
pembrolizumab (5) 5
phase-ii (5) 5
piperazines - therapeutic use (5) 5
prostatic neoplasms - drug therapy (5) 5
abridged index medicus (4) 4
active control (4) 4
adults (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antimetabolites, antineoplastic - adverse effects (4) 4
antineoplastic agents - chemistry (4) 4
bias (4) 4
bortezomib (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Discovery, ISSN 2159-8274, 03/2013, Volume 3, Issue 3, pp. 245 - 245
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2018, Volume 24, Issue 10, pp. 2268 - 2275
With the approval of immunotherapies for a variety of indications, methods to assess treatment benefit addressing the response patterns observed are important.... 
Confidence intervals | Correlation coefficient | Experimental design | Immunotherapy | Correlation coefficients | Response rates | Clinical trials | Survival | Active control | Cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2018, Volume 24, Issue 10, pp. 2262 - 2267
Purpose: Willi objective response rate (ORR) and progression-free survival as defined by RECIST are weakly associated with overall survival (OS) in trials... 
CELL LUNG-CANCER | FDA APPROVAL | METASTATIC MELANOMA | PEMBROLIZUMAB | ONCOLOGY | ATEZOLIZUMAB | PLATINUM-CONTAINING CHEMOTHERAPY | NIVOLUMAB | CARCINOMA | PROGRESSION | Clinical trials | Exploration | Regression analysis | Patients | Survival | Data bases | Regression models | Randomization | Databases | Experimental design | Immunotherapy | Active control | Tumors | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2017, Volume 35, Issue 33, pp. 3745 - 3752
Clinical trial eligibility criteria are necessary to define the patient population under study and improve trial safety. However, there are concerns that... 
ENROLLMENT | MANAGEMENT | ONCOLOGY | CANCER | METASTASES | Drug Discovery - methods | Neoplasms - therapy | Clinical Trials as Topic - methods | Early Detection of Cancer - methods | History, 21st Century | Humans | Index Medicus | Special Series ASCO Special
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 14, pp. 3479 - 3483
On November 23, 2015, the FDA approved nivolumab (OPDIVO; Bristol-Myers Squibb) as a single agent for the first-line treatment of patients with BRAFV600... 
Regulatory agencies | Exanthema | Medical treatment | Melanoma | Medical services | Clinical trials | Diarrhea | Fatigue | Nausea | Metastasis | Pruritus | FDA approval | Survival | Patients | Metastases | Confidence intervals | Dacarbazine | Pain | Risk assessment | Constipation | Cancer | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2017, Volume 23, Issue 23, pp. 7165 - 7170
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e18144 - e18144
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2018, Volume 24, Issue 8, pp. 1780 - 1784
Cancer therapeutics frequently lead to symptomatic adverse events (AE) that can affect treatment tolerability. The NCI has developed the Patient-Reported... 
PATIENT | OUTCOMES | ONCOLOGY | ADVERSE EVENTS | Clinical trials | Medical research | Safety | Patients | Cancer | Quality of life
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2008, Volume 14, Issue 2, pp. 352 - 359
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.